About Saimirra
Saimirra is a Healthcare company based in Chennai (India) by V S Raman. It manufactures and exports pharmaceutical formulations, API, and CRO services for global markets. It operates on a B2B model. The company has 154 employees. Its Indian entity Saimirra Innopharm Private Limited reported revenue of ₹133 Cr. Saimirra offers products and services including Formulations, API, and CRO Services. Its focus areas include Biotech, CRO Services, Bio-equivalence and Pharmaceuticals. Its competitors include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed competitors have raised funding.
Company details
Sai Mirra Innopharm Private Limited is a pharmaceutical company based in Chennai, India, specializing in research, development, manufacturing, and marketing of active pharmaceutical ingredients (API) and formulations. It exports products to over 55 countries, emphasizing quality, innovation, and ethical practices. The company serves domestic and international markets through its integrated operations, including CRO and bio-equivalence services, to meet global healthcare needs.
- Headquarters Chennai, India
- Employees 154
- Founders V S Raman
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website saimirra.com
- Legal Name Sai Mirra Innopharm Private Limited.
- Date of Incorporation 06 Mar, 2000
- Jurisdiction Chennai, Tamil Nadu, India
- Annual Revenue₹133 Cr
FY 2025 · +65% YoY
- Net Profit₹5.07 Cr
FY 2025 · 4% margin
- EBITDA₹41.11 Cr
FY 2025 · 31% margin
- Latest Funding Round$18.8M (USD), Debt – Conventional
Apr 2025
- Investors
- Employee Count154
Associated legal entities of Saimirra
Saimirra operates through Saimirra Innopharm Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Saimirra Innopharm Private Limited CIN U24232TN2000PTC044315 | Active | 06 Mar 2000 | Chennai, Tamil Nadu | ₹133 Cr | 154 | 7 | View details |
Products & Services of Saimirra
Saimirra offers a comprehensive portfolio of products and services, including Formulations, API, and CRO Services.
Manufactures pharmaceutical formulations for export to global markets.
Produces active pharmaceutical ingredients for drug manufacturing.
Offers contract research and bio-equivalence testing services.
Funding Insights of Saimirra
- Total Rounds 1
- Last Round Debt – Conventional — $18.8M
- First Round $18.8M
(Apr 2025)
- Investors Count 1
All 1 funding rounds of Saimirra with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2025 | $18.8M | Debt – Conventional | – | – |
1 investors in total: 1 institutional.
Investors in Saimirra
Saimirra has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Piramal Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| piramal.com |
Investor details for Saimirra
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Saimirra Innopharm Private Limited (Saimirra)
Saimirra Innopharm Private Limited is the primary company behind Saimirra. The board of Saimirra Innopharm Private Limited currently have 6 directors; the longest-serving is Jaganathan Jayaseelan, appointed in 2012. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jaganathan Jayaseelan DIN 01688806 | Director | 18 Jul 2012 | 14 yrs 3 mo | Saimirra Innopharm Private Limited |
| Ayyavu Rajavel DIN 02751833 | Alternate Director | 22 Oct 2012 | 14 yrs | Saimirra Innopharm Private Limited |
| Shanmugam Muthusamy DIN 02684873 | Director | 22 Oct 2012 | 14 yrs | Saimirra Innopharm Private Limited |
| Thanigainathan Thirumurugan DIN 06624713 | Director | 14 Jun 2013 | 13 yrs 4 mo | Saimirra Innopharm Private Limited |
| Bernice Sugirtha DIN 01728390 | Director | 09 Jul 2024 | 2 yrs 3 mo | Saimirra Innopharm Private Limited |
| Abhishek Jain DIN 10948377 | Nominee Director | 19 Jul 2025 | 1 yr 3 mo | Saimirra Innopharm Private Limited |
People of Saimirra
1 people are tracked at Saimirra (1 in leadership); the tracked headcount is 154.
| Name | Role | Group |
|---|---|---|
V S Raman | Founder | Leadership |
Complete people profiles for Saimirra
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Saimirra
Figures of Saimirra Innopharm Private Limited, the primary company behind Saimirra, for FY 2025. Revenue was ₹133 Cr (+65% year on year). Net profit was ₹5.07 Cr (4% margin). EBITDA was ₹41.11 Cr (31% margin). Revenue has grown at a compounded annual rate of +25% over three years and +19% over five years.
- ₹133 CrRevenue · FY 2025 · +65% YoY
- ₹5.07 CrNet profit · 4% margin
- ₹41.11 CrEBITDA · 31% margin
- ₹16.00 CrPaid-up capital
- 154Employees (provident fund records)
- +25%Revenue CAGR, 3 years
- +19%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Saimirra Innopharm Private Limited are on its company page.
Detailed financial statements for Saimirra
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Saimirra
Saimirra has 3 listed competitors in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed competitors of Saimirra
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Saimirra
The website of Saimirra (saimirra.com) receives about 1.2K visits a month.
- Monthly visits1.2K
▲ 55.8% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Saimirra (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Saimirra
Complete news archive for Saimirra
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Saimirra
Saimirra is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
Saimirra has 154 employees.
The primary company behind Saimirra, Saimirra Innopharm Private Limited, reported revenue of ₹133 Cr for FY 2025, up 65% year on year.
Sai Mirra Innopharm Private Limited is a pharmaceutical company based in Chennai, India, specializing in research, development, manufacturing, and marketing of active pharmaceutical ingredients (API) and formulations. It exports products to over 55 countries, emphasizing quality, innovation, and ethical practices. The company serves domestic and international markets through its integrated operations, including CRO and bio-equivalence services, to meet global healthcare needs.
Saimirra's top competitors include Laurus Labs, Symbiotec and SeQuent.
Saimirra offers Formulations, API, and CRO Services.
Saimirra has 1 investor. Key investors include Piramal Group.
Saimirra operates through Saimirra Innopharm Private Limited.
The legal entities of Saimirra currently have 7 directors, including Ayyavu Rajavel, Shanmugam Muthusamy, Jaganathan Jayaseelan and others.